Genzyme Corporation is an American biotechnology company based in Cambridge, Massachusetts. Since its acquisition in 2011, Genzyme has been a fully owned subsidiary of Sanofi. In 2010 Genzyme was the world’s third-largest biotechnology company, employing more than 11,000 people around the world. As a subsidiary of Sanofi, Genzyme has a presence in approximately 65 countries, including 17 manufacturing facilities and 9 genetic-testing laboratories, its products are sold in 90 countries. In 2007, Genzyme generated $3.8 billion in revenues with more than 25 products in the market. (source: Wikipedia)
What Genzyme Says
“BlueCielo Meridian will take us to new levels of efficiency and compliance. The FDA Module provides the technical controls related to compliance with 21 CFR Part 11 necessary for our engineering drawings.”
– Director Global Engineering, Genzyme
BlueCielo respects our customers’ wishes and their need for privacy.
At our customer’s request, we cannot divulge details of this BlueCielo Meridian implementation or the specific improvements it delivered. If you would like to learn more about our solutions for Pharmaceutical, or discuss your requirements, please contact us to arrange a private discussion.